Skip to content
← Lobby register
O&
Other

Organon & Co

🇪🇺 UNITED STATESRegistered 28/01 staff
Disclosed budget
€50,000 — €99,999
Meetings 12mo
0
Policy files
0
Accredited passes
0

Recent meetings

DateCommissioner / CabinetTopicFile
29 Jan 2025
Sabine Weyand
Director-General
Transatlantic trade relations in the second Trump administration.SRC
29 Jan 2025
Matthias Jorgensen
Head of Unit
Transatlantic trade relations in the second Trump administration.SRC
29 Jan 2025
Chiara Galiffa
Cabinet member
EU-US trade
29 Jan 2025
Matthias Jorgensen
Head of Unit
Transatlantic trade relations in the second Trump administration.
29 Jan 2025
Sabine Weyand
Director-General
Transatlantic trade relations in the second Trump administration.
29 Jan 2025
Chiara Galiffa
Cabinet member
EU-US tradeSRC
27 Jan 2025
Ioan-Dragos Tudorache
Cabinet member
Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges.
27 Jan 2025
Ioan-Dragos Tudorache
Cabinet member
Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges.SRC

Mission & Goals

Organon is a biopharmaceutical company. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. And we bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.

EU Legislative Interests

Women Health Sexual Health and rights Family Planning Fertility Biosimilar pharmaceutical products Joint Procurement Pharmaceutical Products pricing Environment protection Pharmaceutical legislation GDPR MDR REACH

Communication Activities

Round table discussions on women health and well - being in Europe Collaboration with European Parliamentary Forum for Sexual Health and Rights on Contraception Atlas and sexual health education Collaboration with Vlerick Business School on economical aspects of investing in women health Collaboration with Fertility Europe on Fertility emotional journey and access to treatment Collaboration with European Institute for Women's Health on overall EU women health strategy

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EUCOPE: https://www.eucope.org/ Biopharmaceutical Industry Organization: https://www.bio.org/ OECD EMNET: https://www.oecd.org/dev/emnet-emerging-markets-network.htm American Central Europe Business Association: https://aceba.org/ Pharmaceutical Aerosol Consortium: https://www.ipacrs.org/ US - Asean Business Council: https://www.usasean.org/ US - China Business Council: https://www.uschina.org/ Latin American Federation of the Pharmaceutical Industry: https://fifarma.org/en/about/

Organisation Members

MABEL Fund: https://gbiomed.kuleuven.be/english/research/50000715/52577001/mabel Business Council for International Understanding (BCIU): https://bciu.org/ World Economic Forum: https://www.weforum.org/

Additional Information

support for ongoing public affairs activities in Brussels

Organon & Co — EU Lobby Register | GovLens